| 000 | 01818 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516150710.0 | ||
| 264 | 0 | _c20140806 | |
| 008 | 201408s 0 0 spa d | ||
| 022 | _a1579-2021 | ||
| 024 | 7 |
_a10.1016/j.endonu.2013.01.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartínez Díaz-Guerra, Guillermo | |
| 245 | 0 | 0 |
_a[Normocalcemic primary hyperparathyroidism: recommendations for management and follow-up]. _h[electronic resource] |
| 260 |
_bEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion _cOct 2013 |
||
| 300 |
_a456.e1-6 p. _bdigital |
||
| 500 | _aPublication Type: Consensus Development Conference; Journal Article; Practice Guideline | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFractures, Spontaneous _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperparathyroidism, Primary _xblood |
| 650 | 0 | 4 |
_aHyperparathyroidism, Secondary _xdiagnosis |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteoporosis _xetiology |
| 650 | 0 | 4 |
_aParathyroid Hormone _xblood |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aVitamin D _xanalogs & derivatives |
| 700 | 1 | _aJódar Gimeno, Esteban | |
| 700 | 1 | _aReyes García, Rebeca | |
| 700 | 1 | _aGómez Sáez, José Manuel | |
| 700 | 1 | _aMuñoz-Torres, Manuel | |
| 773 | 0 |
_tEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion _gvol. 60 _gno. 8 _gp. 456.e1-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.endonu.2013.01.015 _zAvailable from publisher's website |
| 999 |
_c22737767 _d22737767 |
||